BioStock: BiBBInstruments aims for US market entry in 2023

Lund-based BiBBInstruments is developing the world’s first electric biopsy instrument, EndoDrill, with the ambition of facilitating and accelerating the diagnosis of some of the most serious cancer forms. The company’s recent meetings with the FDA, following a market entry application, put EndoDrill on a clear regulatory pathway to US market access. A green light from the FDA would thus grant the company access to the largest and most important market for EUS endoscopy.

Read the full article about BiBBInstruments at biostock.se:

https://www.biostock.se/en/2022/06/bibbinstruments-aims-for-us-market-entry-in-2023/


This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/